Fairfield Financial Advisors LTD lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 23.8% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 6,090 shares of the medical equipment provider's stock after acquiring an additional 1,169 shares during the period. Intuitive Surgical accounts for about 1.1% of Fairfield Financial Advisors LTD's portfolio, making the stock its 19th largest position. Fairfield Financial Advisors LTD's holdings in Intuitive Surgical were worth $3,016,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently modified their holdings of the company. Chilton Capital Management LLC grew its stake in shares of Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after acquiring an additional 43 shares in the last quarter. Parvin Asset Management LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth about $26,000. Global Financial Private Client LLC boosted its holdings in shares of Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after buying an additional 38 shares during the last quarter. Elite Financial Inc. bought a new position in Intuitive Surgical during the first quarter worth about $26,000. Finally, Hurley Capital LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth about $28,000. Institutional investors and hedge funds own 83.64% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently weighed in on ISRG shares. Robert W. Baird lowered their target price on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. BTIG Research raised their price objective on Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research report on Wednesday, July 23rd. Wells Fargo & Company lifted their price target on Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a research report on Wednesday, July 23rd. Wall Street Zen raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. Finally, Truist Financial boosted their price target on Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a research note on Wednesday, July 23rd. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $595.95.
Get Our Latest Stock Report on ISRG
Insider Activity at Intuitive Surgical
In related news, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the transaction, the senior vice president directly owned 907 shares in the company, valued at approximately $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the firm's stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 15,903 shares of company stock worth $7,932,778. 0.70% of the stock is owned by corporate insiders.
Intuitive Surgical Stock Down 2.0%
Shares of NASDAQ:ISRG traded down $9.35 during trading on Thursday, hitting $464.72. The stock had a trading volume of 614,725 shares, compared to its average volume of 2,003,950. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The stock has a market capitalization of $166.59 billion, a price-to-earnings ratio of 64.87, a price-to-earnings-growth ratio of 5.00 and a beta of 1.59. The stock has a 50-day simple moving average of $519.86 and a two-hundred day simple moving average of $531.12.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The firm had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. During the same period last year, the business posted $1.78 earnings per share. The company's revenue for the quarter was up 21.4% compared to the same quarter last year. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.
Intuitive Surgical Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.